Effects of peroxisome proliferator-activated receptor δ on placentation, adiposity, and colorectal cancer
Open accessThe DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
Targeting of the nuclear prostaglandin receptor peroxisome proliferator-activated receptor δ (PPAR δ ) by homologous recombination results in placental defects and frequent (>90%) midgestation lethality. Surviving PPARδ −/− mice exhibit a striking reduction in adiposity relative to wild-type levels. This effect is not reproduced in mice harboring an adipose tissue-specific deletion of PPAR δ , and thus likely reflects peripheral PPARδ functions in systemic lipid metabolism. Finally, we observe that PPAR δ is dispensable for polyp formation in the intestine and colon of APC min mice, inconsistent with its recently proposed role in the establishment of colorectal tumors. Together, these observations reveal specific roles for PPAR δ in embryo development and adipocyte physiology, but not cancer.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“PPAR-δ -/-mice showed a reduction in adiposity compared to wild-type animals, which revealed that PPAR-δ is highly involved in the systemic lipid metabolism [143] and regulation of serum/hepatic triglyceride levels [144,145]”
From Nuclear receptors in liver fibrosis (2021) · cites this paper as [143]
In the citing paper
“PPAR-δ -/-mice showed a reduction in adiposity compared to wild-type animals, which revealed that PPAR-δ is highly involved in the systemic lipid metabolism [143] and regulation of serum/hepatic triglyceride levels [144,145]”
From Nuclear receptors in liver fibrosis (2021) · cites this paper as [143]
Citations
Cites
The nuclear receptor superfamily: the second decade
Mangelsdorf, D. J., Thummel, C., Beato, M., Herrlich, P., Schütz, G., Umesono, K., Blumberg, B., Kastner, P., Mark, M., Chambon, P., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90199-x · Cited by 6,964
Self-citationGeneralized lacZ expression with the ROSA26 Cre reporter strain
Soriano, P. (1999) · Nature Genetics · doi:10.1038/5007 · Cited by 4,859
Activation of β-Catenin-Tcf Signaling in Colon Cancer by Mutations in β-Catenin or APC
Morin, P. J., Sparks, A. B., Korinek, V., Barker, N., Clevers, H., Vogelstein, B., & Kinzler, K. W. (1997) · Science · doi:10.1126/science.275.5307.1787 · Cited by 3,942
Mechanisms of fatty acid-induced inhibition of glucose uptake.
Boden, G., Chen, X., Ruiz, J., White, J. V., & Rossetti, L. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117252 · Cited by 3,705
Lehmann, J. M., Moore, L. B., Smith-Oliver, T. A., Wilkison, W. O., Willson, T. M., & Kliewer, S. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.22.12953 · Cited by 3,625
Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factor
Tontonoz, P., Hu, E., & Spiegelman, B. M. (1994) · Cell · doi:10.1016/0092-8674(94)90006-x · Cited by 3,529
15-Deoxy-Δ12,14-Prostaglandin J2 is a ligand for the adipocyte determination factor PPARγ
Forman, B. M., Tontonoz, P., Chen, J., Brun, R. P., Spiegelman, B. M., & Evans, R. M. (1995) · Cell · doi:10.1016/0092-8674(95)90193-0 · Cited by 2,858
Self-citationForman, B. M., Chen, J., & Evans, R. M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.9.4312 · Cited by 2,116
Self-citationPPARγ Is Required for Placental, Cardiac, and Adipose Tissue Development
Barak, Y., Nelson, M. C., Ong, E. S., Jones, Y. Z., Ruiz-Lozano, P., Chien, K. R., Koder, A., & Evans, R. M. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80209-9 · Cited by 1,956
Self-citationPPARγ Promotes Monocyte/Macrophage Differentiation and Uptake of Oxidized LDL
Tontonoz, P., Nagy, L., Alvarez, J. G. A., Thomazy, V. A., & Evans, R. M. (1998) · Cell · doi:10.1016/s0092-8674(00)81575-5 · Cited by 1,797
Self-citation
Research works printed but not linked: 1
- 10.1101/gad.7.7b.1318 · doi:10.1101/gad.7.7b.1318 · Paper page
Cited by
Items 301–400 of 590
PPARβ Regulates Liver Regeneration by Modulating Akt and E2f Signaling
Liu, H., Fang, Y., Hu, Y. C., Gonzalez, F. J., Fang, J., & Wan, Y. Y. (2013) · PLoS ONE · doi:10.1371/journal.pone.0065644 · Cited by 40
PPAR trilogy from metabolism to cancer
Nahle, Z. A. (2004) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/01.mco.0000134360.30911.bb · Cited by 36
Dong, C., Zhou, H., Shen, C., Yu, L., Ding, Y., Zhang, Y., & Guo, Z. (2015) · World Journal of Diabetes · doi:10.4239/wjd.v6.i4.654 · Cited by 37
Martínez, N., Capobianco, E., White, V., Pustovrh, M. C., Higa, R., & Jawerbaum, A. (2008) · Reproduction · doi:10.1530/rep-08-0028 · Cited by 37
Maternal Metabolism and Vascular Adaptation in Pregnancy: The PPAR Link
Ganß, R. (2016) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2016.09.004 · Cited by 38
Bevilacqua, A., Franco, F., Lu, Y.-T., Rahiman, N., Kao, K., Chuang, Y., Zhu, Y., Held, W., Xie, X., Gunsalus, K. C., et al. (2024) · Science Immunology · doi:10.1126/sciimmunol.adn2717 · Cited by 35
Macrophage alternative activation confers protection against lipotoxicity-induced cell death
Dai, L., Bhargava, P., Stanya, K. J., Alexander, R., Liou, Y.-H., Jacobi, D., Knudsen, N. H., Hyde, A. L., Gangl, M. R., Liu, S., et al. (2017) · Molecular Metabolism · doi:10.1016/j.molmet.2017.08.001 · Cited by 37
Wagner, K., Benchetrit, M., Bianchini, L., Michiels, J., & Wagner, N. (2011) · The Journal of Pathology · doi:10.1002/path.2910 · Cited by 33
Borland, M. G., Khozoie, C., Albrecht, P. P., Zhu, B., Lee, C., Lahoti, T. S., Gonzalez, F. J., & Peters, J. M. (2011) · Cellular Signalling · doi:10.1016/j.cellsig.2011.07.020 · Cited by 36
Coll, T., Barroso, E., Álvarez-Guardia, D., Serrano, L., Salvadó, L., Merlos, M., Palomer, X., & Vázquez‐Carrera, M. (2010) · PPAR Research · doi:10.1155/2010/368467 · Cited by 38
Zolini, A. M., Block, J., Rabaglino, M. B., Tríbulo, P., Hoelker, M., Rincón, G., Bromfield, J. J., & Hansen, P. J. (2019) · Biology of Reproduction · doi:10.1093/biolre/ioz190 · Cited by 37
Santoro, M., Amicis, F. D., Aquila, S., & Bonofiglio, D. (2020) · Human Reproduction · doi:10.1093/humrep/deaa153 · Cited by 38
Placental Implications of Peroxisome Proliferator‐Activated Receptors in Gestation and Parturition
Borel, V., Gallot, D., Marceau, G., Sapin, V., & Blanchon, L. (2008) · PPAR Research · doi:10.1155/2008/758562 · Cited by 39
Peroxisome Proliferator‐Activated Receptors and Progression of Colorectal Cancer
Wang, D., & DuBois, R. N. (2008) · PPAR Research · doi:10.1155/2008/931074 · Cited by 31
Peters, J. M., Morales, J. L., & Gonzalez, F. J. (2011) · Drug Discovery Today Disease Mechanisms · doi:10.1016/j.ddmec.2011.11.002 · Cited by 32
Hellmold, H., Zhang, H., Andersson, U., Blomgren, B., Holland, T., Berg, A., Elebring, M., Sjögren, N., Bamberg, K., Dahl, B., et al. (2007) · Toxicological Sciences · doi:10.1093/toxsci/kfm094 · Cited by 32
Gillio‐Meina, C., Phang, S. H., Mather, J. P., Knight, B. S., & Kennedy, T. G. (2009) · Reproduction · doi:10.1530/rep-08-0294 · Cited by 31
The Role of PPARs in the Endothelium: Implications for Cancer Therapy
Bishop‐Bailey, D., & Swales, K. E. (2008) · PPAR Research · doi:10.1155/2008/904251 · Cited by 31
Obesity: Genomics and Postgenomics
Capel, F. (2007) · CRC Press eBooks · doi:10.3109/9781420020137 · Cited by 34
el Azzouzi, H., Leptidis, S., Bourajjaj, M., Armand, A., van der Nagel, R., van Bilsen, M., Martins, P. A. D. C., & Windt, L. J. D. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.220525 · Cited by 33
Delage, B., Rullier, A., Capdepont, M., Rullier, É., & Cassand, P. (2007) · Nutrition Journal · doi:10.1186/1475-2891-6-20 · Cited by 30
Kang, H. J., Hwang, S.-G., Yoon, J. A., Jun, J. H., Lim, H. J., Yoon, T. K., & Song, H. (2011) · Molecular Human Reproduction · doi:10.1093/molehr/gar030 · Cited by 30
Ahmed, N., Riley, C. B., & Quinn, M. A. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604306 · Cited by 33
Quang, T. H., Ngân, N. T. T., Minh, C. V., Kiệm, P. V., Tài, B. H., Nhiệm, N. X., Thảo, N. P., Luyen, B. T. T., Yang, S. Y., & Kim, Y. H. (2012) · Phytotherapy Research · doi:10.1002/ptr.4871 · Cited by 35
Kwak, H., Hwang, I., Kim, J., Kim, M. Y., Yang, J., & Jeong-Yu, S. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0214 · Cited by 32
The Potential Role of PPARs in the Fetal Origins of Adult Disease
Guo, J., Wu, J., He, Q., Zhang, M., Li, H., & Liu, Y. (2022) · Cells · doi:10.3390/cells11213474 · Cited by 31
Giaginis, C., Spanopoulou, E., & Theocharis, S. E. (2008) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.12.8.1049 · Cited by 36
The Role of Peroxisome Proliferator-Activated Receptors in Pulmonary Vascular Disease
Nisbet, R. E., Sutliff, R. L., & Hart, C. M. (2007) · PPAR Research · doi:10.1155/2007/18797 · Cited by 30
Bargar, T. A., Garrison, V. H., Alvarez, D. A., & Echols, K. R. (2013) · Marine Pollution Bulletin · doi:10.1016/j.marpolbul.2013.03.001 · Cited by 28
Yang, L., Zhou, Z.-G., Zheng, X., Wang, L., Yu, Y., Zhou, B., Gu, J., & Li, Y. (2008) · Diseases of the Colon & Rectum · doi:10.1007/s10350-007-9145-8 · Cited by 31
Fauti, T., Müller‐Brüsselbach, S., Kreutzer, M., Rieck, M., Meißner, W., Rapp, U. R., Schweer, H., Kömhoff, M., & Müller, R. (2005) · FEBS Journal · doi:10.1111/j.1742-4658.2005.05055.x · Cited by 28
Zeng, L., Geng, Y., Tretiakova, M., Yu, X., Siciński, P., & Kroll, T. G. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0855 · Cited by 31
Higa, R., González, E., Pustovrh, M. C., White, V., Capobianco, E., Martínez, N., & Jawerbaum, A. (2006) · Molecular Human Reproduction · doi:10.1093/molehr/gal104 · Cited by 34
Development of Improved PPARβ/δ Inhibitors
Toth, P. M., Naruhn, S., Pape, V. F. S., Dörr, S., Klebe, G., Müller, R., & Diederich, W. E. (2011) · ChemMedChem · doi:10.1002/cmdc.201100408 · Cited by 31
PPARδ Elicits Ligand-Independent Repression of Trefoil Factor Family to Limit Prostate Cancer Growth
Martín-Martín, N., Zabala‐Letona, A., Fernández‐Ruiz, S., Arreal, L., Camacho, L., Castillo-Martín, M., Cortázar, A. R., Torrano, V., Astobiza, I., Zúñiga-García, P., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-0908 · Cited by 35
Shekhawat, P., Yang, H.-S., Bennett, M. J., Carter, A. L., Matern, D., Tamai, I., & Ganapathy, V. (2004) · Pediatric Research · doi:10.1203/01.pdr.0000134252.02876.55 · Cited by 28
Yang, L., Olsson, B., Pfeifer, D., Jönsson, J., Zhou, Z. G., Jiang, X., Fredriksson, B. ‐., Zhang, H., & Sun, X. F. (2009) · Oncogene · doi:10.1038/onc.2009.370 · Cited by 30
Nair, R., Kerätär, J. M., Autio, K. J., Masud, A. J., Finnilä, M., Autio‐Harmainen, H., Miinalainen, I., Nieminen, P. A., Hiltunen, J. K., & Kastaniotis, A. J. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx105 · Cited by 30
Idrees, M., Xu, L., El-Sheikh, M., Sidrat, T., Song, S., Joo, M., Lee, K., & Kong, I. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20236066 · Cited by 30
Modulation of PPAR signaling disrupts pancreas development in the zebrafish, Danio rerio
Venezia, O. L., Islam, S. T., Cho, C., Timme‐Laragy, A. R., & Sant, K. E. (2021) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2021.115653 · Cited by 27
Liu, J., Wang, P., He, L., Li, Y., Luo, J., Cheng, L., Qin, Q., Brako, L. A., Lo, W.-K., Lewis, W., et al. (2011) · PPAR Research · doi:10.1155/2011/372854 · Cited by 29
Kasture, V., Sundrani, D. P., Dalvi, S., Swamy, M., Kale, A. A., & Joshi, S. (2019) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-019-03599-4 · Cited by 28
Transcriptional and Non-Transcriptional Functions of PPARβ/δ in Non-Small Cell Lung Cancer
Genini, D., García‐Escudero, R., Carbone, G. M., & Catapano, C. V. (2012) · PLoS ONE · doi:10.1371/journal.pone.0046009 · Cited by 33
Dongiovanni, P., & Valenti, L. V. C. (2013) · PPAR Research · doi:10.1155/2013/452061 · Cited by 27
The Emerging Role of PPAR Beta/Delta in Tumor Angiogenesis
Du, S., Wagner, N., & Wagner, K. (2020) · PPAR Research · doi:10.1155/2020/3608315 · Cited by 28
PPAR Ligands for Cancer Chemoprevention
Yasui, Y., Kim, M.-H., & Tanaka, T. (2008) · PPAR Research · doi:10.1155/2008/548919 · Cited by 25
Liang, Y.-J., Liu, Y.-C., Chen, C., Lai, L., Shyu, K., Juang, S.-J., Wang, B.-W., & Leu, J.-G. (2009) · International Journal of Cardiology · doi:10.1016/j.ijcard.2009.03.100 · Cited by 29
Branched‐chain fatty acids as activators of peroxisome proliferator‐activated receptors
Hanhoff, T., Benjamin, S., Börchers, T., & Spener, F. (2005) · European Journal of Lipid Science and Technology · doi:10.1002/ejlt.200401076 · Cited by 26
Knutsen, H. K., Ølstørn, H. B., Paulsen, J. E., Husøy, T., Goverud, I. L., Løberg, E. M., Kristiansen, K., & Alexander, J. (2005) · PubMed · Cited by 28
Cyclo-oxygenase 2 inhibitors: emerging roles in the gut
Grover, J. K., Yadav, S., Vats, V., & Joshi, Y. (2003) · International Journal of Colorectal Disease · doi:10.1007/s00384-002-0443-2 · Cited by 28
Genetic Variants of Peroxisome Proliferator-Activated Receptor δ Are Associated with Gastric Cancer
Jeon, C. Y., Chang, S., Mu, L., Zhao, J., Rao, J., Lu, Q., & Zhang, Z. (2013) · Digestive Diseases and Sciences · doi:10.1007/s10620-013-2770-2 · Cited by 24
Kores, K., Kolenc, Z., Furlan, V., & Bren, U. (2022) · Foods · doi:10.3390/foods11091253 · Cited by 24
The impact of early pregnancy metabolic disorders on pregnancy outcome and the specific mechanism
Zhu, X.-Z., Deng, Z., Dai, F., Liu, H., & Cheng, Y. (2023) · European journal of medical research · doi:10.1186/s40001-023-01161-z · Cited by 30
Bogacka, I., Bogacki, M., Gaglewska, M., Kurzyńska, A., & Wasielak, M. (2013) · PubMed · Cited by 24
Monk, J. M., Kim, W., Callaway, E. S., Turk, H. F., Foreman, J. E., Peters, J. M., He, W., Weeks, B. R., Alaniz, R. C., McMurray, D. N., et al. (2011) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00315.2011 · Cited by 25
Self-citationBogacka, I., & Bogacki, M. (2011) · PubMed · Cited by 24
Li, Y., Cheng, L., Qin, Q., Liu, J., Lo, W.-K., Brako, L. A., & Yang, Q. (2009) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2009.07.001 · Cited by 23
Mechanisms of vascular dysfunction in mice with endothelium-specific deletion of the PPAR-δ gene
d’Uscio, L. V., He, T., Santhanam, A. V. R., Tai, L.-J., Evans, R. M., & Katušić, Z. S. (2014) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00761.2013 · Cited by 25
Self-citationThe Role of PPARs in Placental Immunology: A Systematic Review of the Literature
Hutter, S., Knabl, J., Andergassen, U., & Jeschke, U. (2013) · PPAR Research · doi:10.1155/2013/970276 · Cited by 19
PPARδ agonists and metabolic diseases
Kang, K., Hatano, B., & Lee, C. (2007) · Current Atherosclerosis Reports · doi:10.1007/bf02693931 · Cited by 27
Regulation of Cell Proliferation and Differentiation by PPARβ/δ
Müller, R., Rieck, M., & Müller‐Brüsselbach, S. (2008) · PPAR Research · doi:10.1155/2008/614852 · Cited by 27
Lundell, K., Thulin, P., Hamsten, A., & Ehrenborg, E. (2007) · BMC Molecular Biology · doi:10.1186/1471-2199-8-70 · Cited by 27
Dirandeh, E., Towhidi, A., Pirsaraei, Z. A., Saberifar, T., Akhlaghi, A., & Roodbari, A. R. (2014) · Theriogenology · doi:10.1016/j.theriogenology.2014.09.011 · Cited by 21
Phases and Mechanisms of Embryonic Cardiomyocyte Proliferation and Ventricular Wall Morphogenesis
Barak, Y., Hemberger, M., & Sucov, H. M. (2019) · Pediatric Cardiology · doi:10.1007/s00246-019-02164-6 · Cited by 21
Self-citationMultiple Roles of Prostaglandin E2 Receptors in Female Reproduction
Yao, Y., Lin, P., Zhu, J., Jeschke, U., & von Schönfeldt, V. (2020) · Endocrines · doi:10.3390/endocrines1010003 · Cited by 27
Leptin, Acting at Central Level, Increases FGF21 Expression in White Adipose Tissue via PPARβ/δ
Mazuecos, L., Pintado, C., Rubio, B., Guisantes-Batán, E., Andrés, A., & Gallardo, N. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094624 · Cited by 22
Huang, L., Ma, Y., Chen, L., Chang, J., Zhong, M., Wang, Z., Sun, Y., Chen, X., Sun, F., Lu, X., et al. (2021) · The FASEB Journal · doi:10.1096/fj.202002639rrr · Cited by 25
Fan, L., Sweet, D. R., Fan, E., Prosdocimo, D. A., Madera, A., Jiang, Z., Padmanabhan, R., Haldar, S. M., Vinayachandran, V., & Jain, M. K. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.101926 · Cited by 24
Maciejewska, A., Massidda, M., Tocco, F., & Leźnicka, K. (2022) · Nutrients · doi:10.3390/nu14245378 · Cited by 25
Kabine, M., Kebbaj, Z. E., Oaxaca-Castillo, D., Clémencet, M.-C., Kebbaj, M. S. E., Latruffe, N., & Cherkaoui‐Malki, M. (2004) · Biochimie · doi:10.1016/j.biochi.2004.10.003 · Cited by 22
Doroshenko, E. R., Drohomyrecky, P. C., Gower, A., Whetstone, H., Cahill, L. S., Ganguly, M., Spring, S., Yi, T. J., Sled, J. G., & Dunn, S. E. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.570425 · Cited by 26
Carbaprostacyclin, a PPARδ agonist, ameliorates excess lipid accumulation in diabetic rat placentas
Kurtz, M., Capobianco, E., Martínez, N., Fernández, J., Higa, R., White, V., & Jawerbaum, A. (2010) · Life Sciences · doi:10.1016/j.lfs.2010.03.008 · Cited by 22
Growth of transgenic RAF-induced lung adenomas is increased in mice with a disrupted PPARβ/δ gene
Müller‐Brüsselbach, S., Ebrahimsade, S., Jäkel, J., Eckhardt, J., Rapp, U. R., Peters, J. M., Moll, R., & Müller, R. (2007) · International Journal of Oncology · doi:10.3892/ijo.31.3.607 · Cited by 22
Activation of PPAR δ: from computer modelling to biological effects
Kahremany, S., Livne, A., Gruzman, A., Senderowitz, H., & Sasson, S. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12950 · Cited by 24
Outhwaite, J. E., Natale, B. V., Natale, D. R. C., & Simmons, D. G. (2014) · Placenta · doi:10.1016/j.placenta.2014.12.002 · Cited by 20
PFOS Inhibited Normal Functional Development of Placenta Cells via PPARγ Signaling
Li, J., Quan, X., Lei, S., Huang, Z., Wang, Q., & Xu, P. (2021) · Biomedicines · doi:10.3390/biomedicines9060677 · Cited by 27
Peroxisome Proliferator-Activated Receptors in Lung Cancer
Keshamouni, V. G., Han, S., & Roman, J. (2007) · PPAR Research · doi:10.1155/2007/90289 · Cited by 20
The varied roles of nuclear receptors during vertebrate embryonic development
Chung, A. C.-K., & Cooney, A. J. (2003) · Nuclear Receptor Signaling · doi:10.1621/nrs.01007 · Cited by 25
Zhang, Z., Xie, X., Yao, Q., Liu, J., Tian, Y., Yang, C., Xiao, L., & Wang, N. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14745 · Cited by 19
Nuclear Hormone Receptor Modulators for the Treatment of Diabetes and Dyslipidemia
Meinke, P. T., Wood, H. B., & Szewczyk, J. W. (2006) · Annual reports in medicinal chemistry · doi:10.1016/s0065-7743(06)41006-x · Cited by 21
Development of Heterocyclic PPAR Ligands for Potential Therapeutic Applications
Virendra, S. A., Kumar, A., Chawla, P. A., & Mamidi, N. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14102139 · Cited by 20
Targeting peroxisome proliferator-activated receptor-β/δ in colon cancer: How to aim?
Xu, M., Zuo, X., & Shureiqi, I. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2012.09.031 · Cited by 19
Blitek, A., & Szymańska, M. (2017) · Theriogenology · doi:10.1016/j.theriogenology.2017.06.013 · Cited by 19
Zhao, F. L., Ahn, J. J., Chen, E. L. Y., Yi, T. J., Stickle, N. H., Spaner, D., Zúñiga‐Pflücker, J. C., & Dunn, S. E. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1800374 · Cited by 19
Quang, T. H., Ngân, N. T. T., Minh, C. V., Kiệm, P. V., Yến, P. H., Tài, B. H., Nhiệm, N. X., Thảo, N. P., Anh, H. L. T., Luyen, B. T. T., et al. (2012) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.c12-00550 · Cited by 22
PPARγ and PPARδ as Modulators of Neoplasia and Cell Fate
Glazer, R. I., Yuan, H., Xie, Z., & Yin, Y. (2008) · PPAR Research · doi:10.1155/2008/247379 · Cited by 26
Quantitative analysis of PPARδ mRNA by real-time RT-PCR in 86 rectal cancer tissues
Yang, L., Zhou, Z., Luo, H., Zhou, B., Xia, Q. J., & Tian, C. (2005) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2005.11.005 · Cited by 18
Steroid Hormones and Other Lipid Molecules Involved in Human Reproduction
Strauss, J. F., & FitzGerald, G. A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-47912-7.00004-4 · Cited by 32
Zhao, L., Gandhi, C. R., & Gao, Z. (2011) · Liver International · doi:10.1111/j.1478-3231.2011.02632.x · Cited by 19
Balachandar, S., & Katyal, A. (2010) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-010-1122-9 · Cited by 20
Peroxisome proliferator-activated receptor-gamma in normal human pregnancy and miscarriage
Tóth, B., Bastug, M., Mylonas, I. G., Scholz, C., Makovitzky, J., Kunze, S., Thaler, C., Friese, K., & Jeschke, U. (2009) · Acta Histochemica · doi:10.1016/j.acthis.2008.11.020 · Cited by 22
Drohomyrecky, P. C., Doroshenko, E. R., Akkermann, R., Moshkova, M., Yi, T. J., Zhao, F. L., Ahn, J. J., McGaha, T. L., Pahan, K., & Dunn, S. E. (2019) · The Journal of Immunology · doi:10.4049/jimmunol.1801200 · Cited by 21
Li, Y., Wang, C., Lu, J., Huang, K., Han, Y., Chen, J., Yang, Y., & Liu, B. (2019) · International Journal of Medical Sciences · doi:10.7150/ijms.37677 · Cited by 20
YY1 repressing peroxisome proliferator-activated receptor delta promoter
He, C.-Q., Ding, N., & Fan, W. (2007) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-007-9632-1 · Cited by 19
Pathology Analysis of the Placenta
Bolon, B. N. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-394445-0.00014-x · Cited by 21
Salazar, L. A., Inostroza, M., Jara, C., Vega, F., Garcia, R. A., Ciuffardi, Í., & Guzmán, N. H. (2010) · Clinica Chimica Acta · doi:10.1016/j.cca.2010.06.025 · Cited by 19
Peroxisome Proliferator-Activated Receptors Features, Functions, and Future
Youssef, J., & Badr, M. Z. (2015) · Nuclear Receptor Research · doi:10.11131/2015/101188 · Cited by 18
Mousavi, M. S., Shahverdi, A., Drevet, J. R., Akbarinejad, V., Esmaeili, V., Sayahpour, F. A., Topraggaleh, T. R., Rahimizadeh, P., & Masouleh, A. A. M. (2019) · Systems Biology in Reproductive Medicine · doi:10.1080/19396368.2019.1677801 · Cited by 18
Bernal, C., Araya, C., Palma, V., & Bronfman, M. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00078 · Cited by 21
Capobianco, E., Martínez, N., Higa, R., White, V., & Jawerbaum, A. (2008) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2008.08.003 · Cited by 18
Metadata
- Authors
- Barak, Y., Liao, D., He, W., Ong, E. S., Nelson, M. C., Olefsky, J. M., Boland, R., & Evans, R. M.
- Affiliations
- Howard Hughes Medical Institute (US)
- United States Department of Veterans Affairs (US)
- Corresponding author
- Evans, Ronald M.
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2001-12-26
- Volume
- 99
- Issue
- 1
- Pages
- 303-308
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC117556
- OpenAlex
- W2116103211
- Cited by
- 586
- References
- 32
- Citations by year
- 2026: 5 · 2025: 1 · 2024: 12 · 2023: 5 · 2022: 11 · 2021: 16 · 2020: 14 · 2019: 18 · 2018: 8 · 2017: 16 · 2016: 18 · 2015: 18 · 2014: 26 · 2013: 34 · 2012: 28
- FWCI
- 8.98
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Howard Hughes Medical Institute
- March of Dimes Foundation
- Directorate for Biological Sciences
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
- Keywords
- PPARδ, placental development, placentation, adiposity, colorectal cancer, colorectal polyps, ApcMin/+ mice, embryonic development
- MeSH terms
- Adipose Tissue, Alleles, Animals, Body Weight, Exons, Homeostasis, Mice, Transgenic, Models, Genetic, Placenta, Polyps, Recombination, Genetic, Time Factors, Transcription Factors, Colorectal Neoplasms, Receptors, Cytoplasmic and Nuclear, Lipid Metabolism, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.